Hypercalcemia: Clinical Trials

9 trials for Hypercalcemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 not yet recruiting, 1 unknown, 1 withdrawn. 9 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 6, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 24Completed 1, Not yet recruiting 1, Unknown 1, Withdrawn 1

Follow Hypercalcemia: new trials by email Literature Review of Hypercalcemia trials Research Report on Hypercalcemia

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The GranStone Trial
empagliflozin (Jardiance) 25 mg, Losartan 100 mg - Paraffinoma, Granuloma, Foreign-Body
Phase 2 / Phase 3Not yet recruitingMartin Blomberg Jensen1002026-09-012026-09-18
Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers
Vitamin D, Placebo - Asthma, Asthma Exacerbations
Phase 3CompletedProfessor Francine Ducharme3232018-10-012025-06-03
ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
ACTHAR Gel (adrenocorticotropic hormone) - Sarcoidosis, Hypercalcemia Due to Sarcoidosis
Phase 2 / Phase 3UnknownAlbany Medical College102015-02-012015-01-26
An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
Cinacalcet HCl - Parathyroid Carcinoma, Hypercalcemia
Phase 3CompletedKyowa Kirin Co., Ltd.2011-11-012017-03-03
Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D
Placebo, Vitamin D3 - Primary Hyperparathyroidism, Hypercalcemia
Phase 2 / Phase 3WithdrawnColumbia University2010-05-012015-03-05
Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
Cinacalcet, Placebo - Hyperparathyroidism, Primary, Hypercalcemia
Phase 3CompletedAmgen672010-03-102018-10-17
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
Cinacalcet, Placebo - Chronic Allograft Nephropathy, Chronic Kidney Disease
Phase 3CompletedAmgen1142009-12-032018-10-17
Effect of Vitamin D Treatment in Primary Hyperparathyroidism
Cholecalciferol - Vitamin D Deficiency, Primary Hyperparathyroidism
Phase 2 / Phase 3CompletedUniversity of Aarhus462008-05-012013-11-18
Cinacalcet to Treat Familial Primary Hyperparathyroidism
Parathyroid hormone testing, Serum calcium testing - Hypercalcemia, Familial Primary Hyperparathyroidism
Phase 3CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)252006-05-092017-07-02

Narrower conditions

Hyperparathyroidism, Primary (4)  ·  Hypercalciuria (2)  ·  Nephrocalcinosis (2)  ·  Nephrolithiasis (2)  ·  Renal Insufficiency, Chronic (2)  ·  Vitamin D Deficiency (2)  ·  Asthma (1)  ·  Bone Diseases, Metabolic (1)  ·  Carcinoma, Medullary (1)  ·  Gastrinoma (1)  ·  Glomerulonephritis (1)  ·  Granuloma, Foreign-Body (1)  ·  Hyperparathyroidism (1)  ·  Hyperparathyroidism 1 (1)

Broader conditions

Calcium Metabolism Disorders (9)  ·  Metabolic Diseases (9)  ·  Nutritional and Metabolic Diseases (9)  ·  Water-Electrolyte Imbalance (9)  ·  Endocrine System Diseases (6)  ·  Parathyroid Diseases (5)  ·  Hyperparathyroidism (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Male Urogenital Diseases (3)  ·  Pathologic Processes (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Avitaminosis (2)

Interventions

Cholecalciferol (3)  ·  Cinacalcet (3)  ·  Vitamin D (2)  ·  Adrenocorticotropic Hormone (1)  ·  Losartan (1)  ·  empagliflozin (1)

Sponsors

Amgen (2)  ·  Albany Medical College (1)  ·  Columbia University (1)  ·  Kyowa Kirin Co., Ltd. (1)  ·  Martin Blomberg Jensen (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Professor Francine Ducharme (1)  ·  University of Aarhus (1)

Countries

United States (5)  ·  Canada (3)  ·  Australia (2)  ·  Denmark (2)  ·  Poland (2)  ·  Austria (1)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Japan (1)  ·  Portugal (1)  ·  Russia (1)  ·  Spain (1)

Top investigators

Francine M Ducharme, MD (1)  ·  Lars Rejnmark, MD,PhD,DrMed (1)  ·  Lars Rolighed, MD (1)  ·  Marc A Judson, MD (1)  ·  Martin B Jensen, Professor (1)  ·  Shonni J. Silverberg, MD (1)

Results publications

PMID 35018442, PMID 41966354, PMID 42871976

NIH funding

R01DK084986 (1)